<unk>  is advertising the use of drugs for purposes not approved by the regional government. The practice is often illegal and has led to most of the largest pharmaceutical settlements after Franklin v. Parke-Davis, in which a court ruled off-label<unk>  a violation of the False Claims Act.
Marketing of off-label use
Bar code medication administration
Clinical trial naming conventions
Monitored Emergency Use of Unregistered and Investigational Interventions
Interactive patient care
Separation of prescribing and dispensing
Therapeutic discovery project
Discrimination against drug addicts